Abiraterone Acetate Api

Abiraterone Acetate API (CAS No. 154229-18-2) is a premium Active Pharmaceutical Ingredient widely used in the formulation of medications for advanced prostate cancer, including metastatic castration-resistant prostate cancer (mCRPC) and castration-sensitive prostate cancer (mCSPC). It works by blocking androgen biosynthesis, reducing male hormone production that fuels cancer growth. Abiraterone is typically administered orally with prednisone on an empty stomach. Specifications & Details: Product Name: Abiraterone Acetate Synonyms: Abiraterone Acetate Grade: USP / In-House Molecular Formula: C26H33NO2 Molecular Weight: 391.5 g/mol CAS Number: 154229-18-2 COA & MSDS: Available on request Packaging: HDPE drums with double liner bags Storage: Store in air-tight containers, protected from light and moisture Key Features: WHO-GMP certified manufacturing Export quality bulk supply High purity and compliance with international pharmacopeia standards Applications: Used in pharmaceutical formulations for prostate cancer treatment and hormone therapy. Abiraterone Acetate API, Prostate Cancer Treatment, Hormone Therapy Bulk Drug, Pharma Raw Material, Active Pharmaceutical Ingredient, CAS 154229-18-2, USP Grade, WHO-GMP Certified, Pharmaceutical Export. #AbirateroneAcetate #PharmaceuticalAPI #ProstateCancerTreatment #HormoneTherapy #BulkDrugs #ActiveIngredient #PharmaExport #CAS154229-18-2 #USPGrade About the Company GST Registration Date: 2020 Legal Status of Firm: Proprietorship Number of Employees: 11 To 25 People Annual Turnover: 40 L - 1.5 Cr